Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$99,273
-$15,480 QoQ
Shares Held
35,079
-0.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 25.063428261923086.ToString("F0")%
Shared 0.ToString("F0")%
None 74.9365717380769.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,683,576,696 across 351 Biotechnology names. MRVI ranks #244 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,273 | 35,079 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $114,753 | 35,309 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $95,771 | 33,370 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $63,437 | 26,323 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $91,427 | 41,370 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $11,605,507 | 2,129,451 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $20,602,441 | 2,479,235 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $18,890,900 | 2,638,394 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,812,655 | 555,093 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,994,712 | 457,208 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $68,290 | 6,829 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $69,507 | 5,592 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $13,635,302 | 973,255 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,356,286 | 94,779 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $64,531,643 | 2,527,679 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $113,864,521 | 4,007,903 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $332,948,445 | 9,439,990 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $532,450,365 | 12,707,646 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $877,908,485 | 17,887,296 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $527,979,268 | 12,652,271 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $345,823,580 | 9,703,243 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $160,069,063 | 5,706,562 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||